Shatdal Pharma Private Limited - Company Profile

It is a pharma private limited company based in Nagpur, Maharashtra, India, established in 2021.
2021 Nagpur, Maharashtra, India Active
Last Updated:
Access Report
About Shatdal Pharma Private Limited

Shatdal Pharma Private Limited, a active private limited company, was established on 01 February 2021 in Nagpur, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230MH2021PTC354259. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Achal Pralhad Khandare (Director), Suhas Kamlakar Nandgaonkar (Director). Past directors included Pankaj Khemaji Burde, Roshani Pankaj Dhule. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at H. No. 1553/A, Jamdarwadi, Nagpur, Maharashtra, 440017.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH2021PTC354259

  • Registration Number

    354259

  • Incorporation Date

    01 February 2021

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 12 Days
  • Last Filing with ROC 31 Mar 2025
Company report

Shatdal Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Shatdal Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Shatdal Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Achal Pralhad Khandare Director 24 Jun 2025 Current
Suhas Kamlakar Nandgaonkar Director 24 Jun 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 29 Jul 2025 Past
Pramod Abcsdd Director 26 Jun 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Shatdal Pharma.

Shatdal Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Shatdal Pharma revenue growth over time
Shatdal Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Shatdal Pharma?

Unlock access to Shatdal Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Shatdal Pharma?

Shatdal Pharma has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Shatdal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shatdal Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Shatdal Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Shatdal Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Director Appointment

    Achal Pralhad Khandare was appointed as a Director was appointed as a Director on 24 Jun 2025 & has been associated with this company since 7 months 22 days . was recorded as a recent event.

  • Director Appointment

    Suhas Kamlakar Nandgaonkar was appointed as a Director was appointed as a Director on 24 Jun 2025 & has been associated with this company since 7 months 22 days . was recorded as a recent event.

  • Balance Sheet

    Progress on Shatdal Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Company Incorporation

    The activity Shatdal Pharma Private Limited was registered on 01 Feb 2021 with Roc Mumbai & aged 5 years 12 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Shatdal Pharma Private Limited?

The CIN of Shatdal Pharma Private Limited is U24230MH2021PTC354259.

Where is Shatdal Pharma Private Limited headquartered?

Shatdal Pharma Private Limited is headquartered at H. No. 1553/A, Jamdarwadi, Nagpur, Maharashtra, 440017.

When was Shatdal Pharma Private Limited incorporated?

Shatdal Pharma Private Limited was incorporated on 01 February 2021.

Who are the current directors of Shatdal Pharma Private Limited?

The current directors of Shatdal Pharma Private Limited are

What is the primary industry of Shatdal Pharma Private Limited?

The primary industry of Shatdal Pharma Private Limited is Pharma.

Is Shatdal Pharma Private Limited a listed company?

Shatdal Pharma Private Limited is unlisted.

What is the capital structure of Shatdal Pharma Private Limited?

The authorized capital of Shatdal Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available